1. Home
  2. ALGN

as of 12-01-2025 3:42pm EST

$147.44
+$0.75
+0.51%
Stocks Health Care Industrial Specialties Nasdaq

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Chart Type:
Time Range:
Founded: 1997 Country:
United States
United States
Employees: N/A City: TEMPE
Market Cap: 10.2B IPO Year: N/A
Target Price: $190.50 AVG Volume (30 days): 1.5M
Analyst Decision: Buy Number of Analysts: 13
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 5.16 EPS Growth: -11.97
52 Week Low/High: $122.00 - $246.19 Next Earning Date: 10-29-2025
Revenue: $3,982,622,000 Revenue Growth: 0.56%
Revenue Growth (this year): 2.48% Revenue Growth (next year): 3.44%

AI-Powered ALGN Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 77.48%
77.48%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Align Technology Inc. News

ALGN Breaking Stock News: Dive into ALGN Ticker-Specific Updates for Smart Investing

All ALGN News

Share on Social Networks: